Bioavailability of different Curcumin formulations in healthy subjects: a randomized, controlled, cross-over study - BTS1685/20

Apomedica Pharmazeutische Produkte GmbH0 个研究点目标入组 12 人开始时间: 2022年1月26日最近更新: 2024年8月19日

试验速览

暂无简介。

•Main exclusion criteria:
•- Relevant history or presence of any severe medical disorder, potentially interfering with this study
•- Known allergy and hypersensitivity to ingredients of the study product
•- Blood donation within 1 month prior to study start or during study
•- Significant changes in lifestyle or medication (within last 3 months) or surgical intervention or surgical procedure such as bariatric surgery
•- For this study clinically relevant abnormal laboratory, vital signs or physical findings at screening
•- Extreme dietary regimes”: vegan lifestyle, weight loss diet with <1200 kcal/day for women and <1800 kcal for men
•- Regular intake of drugs or supplements possibly interfering with this study within 2 weeks prior to study start or during the study (e.g. curcumin)
•- Chronic intake of substances affecting blood coagulation, which in the investigator’s opinion would impact subject safety
•- Subjects with history of drug, alcohol or other substance abuse, or other factors limiting their ability to co-operate during the study.
•- Known pregnancy, breast feeding or intention to become pregnant during the study.
•- Anticipating any planned changes in lifestyle for the duration of the study

发起方